Get the Stockscreener App
162.25
0.15%
+0.24
BeiGene Ltd ADR Stock (BGNE) Forecast
The BeiGene Ltd ADR (BGNE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $144.25, representing a -11.10% decrease from the current price of $162.25. The highest analyst price target is $152.34, and the lowest is $136.15.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BGNE Price Target
Average 184.96
(+14.00% Upside)
Is BeiGene Ltd ADR (BGNE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.45 | Neutral |
| STOCH(9,6) | 93.31 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 1.5876 | Buy |
| ADX(14) | 23.53 | Neutral |
| William %R | -6.2447 | Sell |
| CCI(14) | 101.50 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
150.74
Buy
|
153.15
Buy
|
| MA20 |
145.70
Buy
|
150.35
Buy
|
| MA50 |
155.51
Buy
|
153.12
Buy
|
| MA100 |
160.20
Buy
|
160.34
Buy
|
| MA200 |
175.29
Sell
|
176.13
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, BGNE could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on BGNE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63.45 indicates that BGNE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 93.31 indicates that BGNE is oversold. This means that BGNE price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that BGNE is oversold. This suggests that BGNE price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.53 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 101.5 indicates that BGNE is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term BGNE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about BeiGene Ltd ADR financial reports and earnings history, BeiGene Ltd ADR (BGNE) stock could reach $185.20 by 2030, $350.73 by 2040 and $346.80 by 2050. See the projected annual prices until 2050 of the BeiGene Ltd ADR stock below:
- BeiGene Ltd ADR (BGNE) is expected to reach an average price of $237.84 in 2035, with a high prediction of $258.50 and a low estimate of $231.82. This indicates an $46.59% rise from the last recorded price of $162.25.
- BeiGene Ltd ADR (BGNE) stock is projected to chart a bullish course in 2040, with an average price target of $333.28, representing an $105.41% surge from its current level. The forecast ranges from a conservative $288.51 to a sky-high $350.73.
- Our analysts predict BeiGene Ltd ADR (BGNE) to jump 46.39% by 2045, soaring from $234.03 to an average price of $237.52, potentially reaching $276.32. While $234.03 is the low estimate, the potential upside is significant.
- BeiGene Ltd ADR (BGNE) stock is expected to climb by 2050, reaching an average of $319.06, a $96.65% jump from its current level. However, a wide range of estimates exists, with high and low targets of $346.80 and $262.18, respectively, highlighting the market's uncertainty.
BeiGene Ltd ADR Stock (BGNE) Year by Year Forecast
BeiGene Ltd ADR Stock (BGNE) Price Forecast for 2024
Our forecast for BGNE stock price in 2024 now indicates an average price target of $180.37 with a high forecast of $233.77 and a low forecast of $126.97. The average prediction reflects an increase of +11.17% from the last recorded price of $162.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $147.15 | $136.15 | $152.34 | -9.30% |
| July, 2024 | $160.33 | $141.62 | $160.55 | -1.19% |
| August, 2024 | $165.98 | $150.82 | $173.20 | +2.30% |
| September, 2024 | $157.70 | $142.03 | $171.89 | -2.80% |
| October, 2024 | $155.93 | $137.83 | $160.37 | -3.89% |
| November, 2024 | $222.07 | $154.99 | $223.38 | +36.87% |
| December, 2024 | $210.84 | $208.74 | $233.77 | +29.95% |
BeiGene Ltd ADR Stock (BGNE) Price Forecast for 2025
BeiGene Ltd ADR Stock (BGNE) is expected to reach an average price of $244.65 in 2025, with a high prediction of $347.10 and a low estimate of $142.21. This indicates an +50.79% rise from the last recorded price of $162.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $185.58 | $180.70 | $216.24 | +14.38% |
| February, 2025 | $176.01 | $174.50 | $197.33 | +8.48% |
| March, 2025 | $177.98 | $173.92 | $197.57 | +9.69% |
| April, 2025 | $147.01 | $142.21 | $187.68 | -9.39% |
| May, 2025 | $184.98 | $145.94 | $189.36 | +14.01% |
| June, 2025 | $190.04 | $160.25 | $190.35 | +17.13% |
| July, 2025 | $206.41 | $178.99 | $206.75 | +27.21% |
| August, 2025 | $219.93 | $202.88 | $228.90 | +35.55% |
| September, 2025 | $244.45 | $228.11 | $279.94 | +50.66% |
| October, 2025 | $264.19 | $231.93 | $278.59 | +62.83% |
| November, 2025 | $310.51 | $250.16 | $311.81 | +91.38% |
| December, 2025 | $320.66 | $305.56 | $347.10 | +97.63% |
BeiGene Ltd ADR Stock (BGNE) Price Forecast for 2026
The predicted value for BeiGene Ltd ADR (BGNE) in 2026 is set at an average of $347.41. Estimates vary from a peak of $451.38 to a trough of $243.44, indicating an +114.12% surge from the present price of $162.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $310.09 | $277.70 | $341.98 | +91.12% |
| February, 2026 | $281.53 | $243.44 | $310.25 | +73.52% |
| March, 2026 | $369.30 | $268.37 | $370.28 | +127.61% |
| April, 2026 | $375.41 | $337.58 | $413.34 | +131.38% |
| May, 2026 | $373.37 | $307.84 | $380.22 | +130.12% |
| June, 2026 | $332.75 | $327.45 | $385.44 | +105.08% |
| July, 2026 | $344.16 | $313.80 | $384.38 | +112.11% |
| August, 2026 | $371.51 | $342.81 | $393.04 | +128.97% |
| September, 2026 | $353.92 | $332.97 | $392.45 | +118.13% |
| October, 2026 | $346.98 | $274.90 | $373.72 | +113.86% |
| November, 2026 | $333.07 | $263.63 | $352.60 | +105.28% |
| December, 2026 | $387.62 | $333.59 | $451.38 | +138.90% |
BeiGene Ltd ADR Stock (BGNE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for BeiGene Ltd ADR (BGNE) is $280.40, with a high forecast of $417.25 and a low forecast of $143.55. This indicates an +72.82% increase from the last price of $162.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $404.35 | $359.80 | $405.58 | +149.21% |
| February, 2027 | $389.49 | $367.20 | $417.25 | +140.06% |
| March, 2027 | $298.73 | $247.23 | $393.49 | +84.12% |
| April, 2027 | $263.71 | $245.10 | $311.03 | +62.53% |
| May, 2027 | $248.88 | $219.60 | $282.43 | +53.40% |
| June, 2027 | $201.56 | $197.70 | $257.55 | +24.23% |
| July, 2027 | $213.85 | $161.31 | $238.11 | +31.80% |
| August, 2027 | $189.08 | $187.04 | $241.65 | +16.54% |
| September, 2027 | $159.33 | $143.55 | $204.10 | -1.80% |
| October, 2027 | $157.56 | $152.93 | $194.87 | -2.89% |
| November, 2027 | $214.21 | $165.31 | $221.87 | +32.03% |
| December, 2027 | $219.51 | $185.95 | $232.81 | +35.29% |
BeiGene Ltd ADR Stock (BGNE) Price Forecast for 2028
In 2028, BeiGene Ltd ADR (BGNE) is projected to reach an average price of $228.32, with a high projection of $306.51 and a low estimate of $150.14. This indicates an +40.72% rise from the last price of $162.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $192.48 | $189.57 | $224.13 | +18.63% |
| February, 2028 | $160.47 | $157.08 | $199.47 | -1.10% |
| March, 2028 | $194.61 | $150.14 | $205.68 | +19.94% |
| April, 2028 | $200.74 | $193.91 | $236.27 | +23.72% |
| May, 2028 | $251.91 | $202.11 | $258.45 | +55.26% |
| June, 2028 | $292.31 | $241.81 | $306.51 | +80.16% |
| July, 2028 | $270.43 | $267.44 | $299.54 | +66.67% |
| August, 2028 | $242.25 | $234.84 | $276.66 | +49.31% |
| September, 2028 | $264.52 | $236.38 | $268.51 | +63.03% |
| October, 2028 | $275.91 | $259.98 | $298.57 | +70.05% |
| November, 2028 | $253.55 | $239.99 | $282.58 | +56.27% |
| December, 2028 | $204.54 | $200.98 | $255.77 | +26.07% |
BeiGene Ltd ADR Stock (BGNE) Price Forecast for 2029
The 2029 price forecast for BeiGene Ltd ADR Stock (BGNE) is $202.69 on average, with a high prediction of $251.53 and a low estimate of $153.86. This represents an +24.92% increase from the previous price of $162.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $240.53 | $204.45 | $251.53 | +48.25% |
| February, 2029 | $224.77 | $210.21 | $242.75 | +38.53% |
| March, 2029 | $226.74 | $217.68 | $246.02 | +39.75% |
| April, 2029 | $205.26 | $193.76 | $237.83 | +26.51% |
| May, 2029 | $225.65 | $183.04 | $230.13 | +39.07% |
| June, 2029 | $214.08 | $207.52 | $231.95 | +31.95% |
| July, 2029 | $207.01 | $197.85 | $215.36 | +27.58% |
| August, 2029 | $174.94 | $174.59 | $211.19 | +7.82% |
| September, 2029 | $181.87 | $159.68 | $185.24 | +12.09% |
| October, 2029 | $178.85 | $178.68 | $211.62 | +10.23% |
| November, 2029 | $156.41 | $153.86 | $186.20 | -3.60% |
| December, 2029 | $179.52 | $156.86 | $184.82 | +10.64% |
BeiGene Ltd ADR Stock (BGNE) Price Forecast for 2030
BeiGene Ltd ADR Stock (BGNE) is expected to reach an average price of $208.20 in 2030, with a high forecast of $257.18 and a low forecast of $159.22. This signifies an +28.32% surge from the last price of $162.25.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $163.81 | $161.72 | $185.20 | +0.96% |
| February, 2030 | $168.82 | $159.22 | $177.88 | +4.05% |
| March, 2030 | $184.31 | $164.74 | $185.32 | +13.60% |
| April, 2030 | $189.39 | $174.00 | $196.40 | +16.73% |
| May, 2030 | $169.09 | $165.25 | $195.11 | +4.21% |
| June, 2030 | $185.73 | $161.14 | $187.37 | +14.47% |
| July, 2030 | $254.31 | $182.74 | $255.78 | +56.74% |
| August, 2030 | $219.93 | $204.15 | $257.18 | +35.55% |
| September, 2030 | $210.59 | $205.35 | $220.64 | +29.79% |
| October, 2030 | $218.14 | $197.49 | $220.86 | +34.45% |
| November, 2030 | $190.29 | $183.72 | $221.16 | +17.28% |
| December, 2030 | $185.88 | $165.87 | $203.15 | +14.56% |
1.62%
7.22%
Cap:
|
Volume (24h):